Quality Culture
At Biocon Biologics, quality is more than a standard — it’s a promise we make to every patient who relies on our therapies. Our culture of quality is deeply rooted in patient safety, regulatory trust, and continuous improvement. Through transparency, accountability, and innovation, we ensure that every decision and action supports our mission: to deliver safe, effective, and accessible biopharmaceuticals that improve lives globally.
Metrics, audits, surveys and feedback regularly measure our quality, and we take prompt action to address any opportunities for improvement. Our quality culture is fostered by:
Listening to our patients, customers, regulators and addressing their needs and concerns
Communicating candidly and transparently aboutquality issues, addressing them on time, and rewarding successes, performance,and best practices
Empowering our employees with resources, training, and tools required to take ownership and accountability of quality
Promoting a learning organization that encourages innovation and continual improvement, while ensuring compliance with applicable laws, regulations, and standards
Driving Quality Excellence
At Biocon Biologics, we are committed to continuously enhancing our processes to deliver world-class products and services. As part of this journey, we introduced the John Shaw Excellence Awards (JSEA) to recognize and reward “Best in Class” Strategic Business Units across the Biocon Group.
JSEA evaluates excellence in quality, cost, innovation, delivery, EHS, and productivity, fostering a culture of high performance and operational excellence. It is designed as a prerequisite to qualify for the Deming Prize, one of the most prestigious awards in the world for quality management.
